img

Global Targeting p53 Cancer Therapies Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Targeting p53 Cancer Therapies Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The essence of p53-targeted therapy is to regain the "tumor suppressor function" of the mutated p53 protein, or indirectly protect the "tumor suppressor function" of p53 by inhibiting other targets that can inhibit the wild-type p53 protein.
Targeting p53 Cancer Therapies report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Targeting p53 Cancer Therapies market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Targeting p53 Cancer Therapies industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Targeting p53 Cancer Therapies key manufacturers include Sibiono GeneTech, Kartos Therapeutics, SynerGene Therapeutics, MultiVir, Rain Oncology, Alieron Therapeutics, Aprea Therapeutics, Ascentage Pharma and Jc (Wuxi) Company, etc. Sibiono GeneTech, Kartos Therapeutics, SynerGene Therapeutics are top 3 players and held % sales share in total in 2022.
Targeting p53 Cancer Therapies can be divided into Small Molecule Drugs, Immunotherapy, Gene Therapy and Others, etc. Small Molecule Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Targeting p53 Cancer Therapies is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Targeting p53 Cancer Therapies industry development. In 2022, global % sales of Targeting p53 Cancer Therapies went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Targeting p53 Cancer Therapies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sibiono GeneTech
Kartos Therapeutics
SynerGene Therapeutics
MultiVir
Rain Oncology
Alieron Therapeutics
Aprea Therapeutics
Ascentage Pharma
Jc (Wuxi) Company
Segment by Type
Small Molecule Drugs
Immunotherapy
Gene Therapy
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Targeting p53 Cancer Therapies market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Targeting p53 Cancer Therapies, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Targeting p53 Cancer Therapies industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Targeting p53 Cancer Therapies in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Targeting p53 Cancer Therapies introduction, etc. Targeting p53 Cancer Therapies Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Targeting p53 Cancer Therapies market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Targeting p53 Cancer Therapies Market Overview
1.1 Targeting p53 Cancer Therapies Product Overview
1.2 Targeting p53 Cancer Therapies Market Segment by Type
1.2.1 Small Molecule Drugs
1.2.2 Immunotherapy
1.2.3 Gene Therapy
1.2.4 Others
1.3 Global Targeting p53 Cancer Therapies Market Size by Type
1.3.1 Global Targeting p53 Cancer Therapies Market Size Overview by Type (2024-2034)
1.3.2 Global Targeting p53 Cancer Therapies Historic Market Size Review by Type (2024-2024)
1.3.3 Global Targeting p53 Cancer Therapies Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Targeting p53 Cancer Therapies Sales Breakdown by Type (2024-2024)
1.4.2 Europe Targeting p53 Cancer Therapies Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Targeting p53 Cancer Therapies Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Targeting p53 Cancer Therapies Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Targeting p53 Cancer Therapies Sales Breakdown by Type (2024-2024)
2 Global Targeting p53 Cancer Therapies Market Competition by Company
2.1 Global Top Players by Targeting p53 Cancer Therapies Sales (2024-2024)
2.2 Global Top Players by Targeting p53 Cancer Therapies Revenue (2024-2024)
2.3 Global Top Players by Targeting p53 Cancer Therapies Price (2024-2024)
2.4 Global Top Manufacturers Targeting p53 Cancer Therapies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Targeting p53 Cancer Therapies Market Competitive Situation and Trends
2.5.1 Targeting p53 Cancer Therapies Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Targeting p53 Cancer Therapies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeting p53 Cancer Therapies as of 2022)
2.7 Date of Key Manufacturers Enter into Targeting p53 Cancer Therapies Market
2.8 Key Manufacturers Targeting p53 Cancer Therapies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Targeting p53 Cancer Therapies Status and Outlook by Region
3.1 Global Targeting p53 Cancer Therapies Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Targeting p53 Cancer Therapies Historic Market Size by Region
3.2.1 Global Targeting p53 Cancer Therapies Sales in Volume by Region (2024-2024)
3.2.2 Global Targeting p53 Cancer Therapies Sales in Value by Region (2024-2024)
3.2.3 Global Targeting p53 Cancer Therapies Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Targeting p53 Cancer Therapies Forecasted Market Size by Region
3.3.1 Global Targeting p53 Cancer Therapies Sales in Volume by Region (2024-2034)
3.3.2 Global Targeting p53 Cancer Therapies Sales in Value by Region (2024-2034)
3.3.3 Global Targeting p53 Cancer Therapies Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Targeting p53 Cancer Therapies by Application
4.1 Targeting p53 Cancer Therapies Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Targeting p53 Cancer Therapies Market Size by Application
4.2.1 Global Targeting p53 Cancer Therapies Market Size Overview by Application (2024-2034)
4.2.2 Global Targeting p53 Cancer Therapies Historic Market Size Review by Application (2024-2024)
4.2.3 Global Targeting p53 Cancer Therapies Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Targeting p53 Cancer Therapies Sales Breakdown by Application (2024-2024)
4.3.2 Europe Targeting p53 Cancer Therapies Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Targeting p53 Cancer Therapies Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Targeting p53 Cancer Therapies Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Targeting p53 Cancer Therapies Sales Breakdown by Application (2024-2024)
5 North America Targeting p53 Cancer Therapies by Country
5.1 North America Targeting p53 Cancer Therapies Historic Market Size by Country
5.1.1 North America Targeting p53 Cancer Therapies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2024)
5.1.3 North America Targeting p53 Cancer Therapies Sales in Value by Country (2024-2024)
5.2 North America Targeting p53 Cancer Therapies Forecasted Market Size by Country
5.2.1 North America Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2034)
5.2.2 North America Targeting p53 Cancer Therapies Sales in Value by Country (2024-2034)
6 Europe Targeting p53 Cancer Therapies by Country
6.1 Europe Targeting p53 Cancer Therapies Historic Market Size by Country
6.1.1 Europe Targeting p53 Cancer Therapies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2024)
6.1.3 Europe Targeting p53 Cancer Therapies Sales in Value by Country (2024-2024)
6.2 Europe Targeting p53 Cancer Therapies Forecasted Market Size by Country
6.2.1 Europe Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2034)
6.2.2 Europe Targeting p53 Cancer Therapies Sales in Value by Country (2024-2034)
7 Asia-Pacific Targeting p53 Cancer Therapies by Region
7.1 Asia-Pacific Targeting p53 Cancer Therapies Historic Market Size by Region
7.1.1 Asia-Pacific Targeting p53 Cancer Therapies Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Targeting p53 Cancer Therapies Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Targeting p53 Cancer Therapies Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Targeting p53 Cancer Therapies Forecasted Market Size by Region
7.2.1 Asia-Pacific Targeting p53 Cancer Therapies Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Targeting p53 Cancer Therapies Sales in Value by Region (2024-2034)
8 Latin America Targeting p53 Cancer Therapies by Country
8.1 Latin America Targeting p53 Cancer Therapies Historic Market Size by Country
8.1.1 Latin America Targeting p53 Cancer Therapies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2024)
8.1.3 Latin America Targeting p53 Cancer Therapies Sales in Value by Country (2024-2024)
8.2 Latin America Targeting p53 Cancer Therapies Forecasted Market Size by Country
8.2.1 Latin America Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2034)
8.2.2 Latin America Targeting p53 Cancer Therapies Sales in Value by Country (2024-2034)
9 Middle East and Africa Targeting p53 Cancer Therapies by Country
9.1 Middle East and Africa Targeting p53 Cancer Therapies Historic Market Size by Country
9.1.1 Middle East and Africa Targeting p53 Cancer Therapies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Targeting p53 Cancer Therapies Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Targeting p53 Cancer Therapies Forecasted Market Size by Country
9.2.1 Middle East and Africa Targeting p53 Cancer Therapies Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Targeting p53 Cancer Therapies Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sibiono GeneTech
10.1.1 Sibiono GeneTech Company Information
10.1.2 Sibiono GeneTech Introduction and Business Overview
10.1.3 Sibiono GeneTech Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sibiono GeneTech Targeting p53 Cancer Therapies Products Offered
10.1.5 Sibiono GeneTech Recent Development
10.2 Kartos Therapeutics
10.2.1 Kartos Therapeutics Company Information
10.2.2 Kartos Therapeutics Introduction and Business Overview
10.2.3 Kartos Therapeutics Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Kartos Therapeutics Targeting p53 Cancer Therapies Products Offered
10.2.5 Kartos Therapeutics Recent Development
10.3 SynerGene Therapeutics
10.3.1 SynerGene Therapeutics Company Information
10.3.2 SynerGene Therapeutics Introduction and Business Overview
10.3.3 SynerGene Therapeutics Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.3.4 SynerGene Therapeutics Targeting p53 Cancer Therapies Products Offered
10.3.5 SynerGene Therapeutics Recent Development
10.4 MultiVir
10.4.1 MultiVir Company Information
10.4.2 MultiVir Introduction and Business Overview
10.4.3 MultiVir Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.4.4 MultiVir Targeting p53 Cancer Therapies Products Offered
10.4.5 MultiVir Recent Development
10.5 Rain Oncology
10.5.1 Rain Oncology Company Information
10.5.2 Rain Oncology Introduction and Business Overview
10.5.3 Rain Oncology Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Rain Oncology Targeting p53 Cancer Therapies Products Offered
10.5.5 Rain Oncology Recent Development
10.6 Alieron Therapeutics
10.6.1 Alieron Therapeutics Company Information
10.6.2 Alieron Therapeutics Introduction and Business Overview
10.6.3 Alieron Therapeutics Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Alieron Therapeutics Targeting p53 Cancer Therapies Products Offered
10.6.5 Alieron Therapeutics Recent Development
10.7 Aprea Therapeutics
10.7.1 Aprea Therapeutics Company Information
10.7.2 Aprea Therapeutics Introduction and Business Overview
10.7.3 Aprea Therapeutics Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Aprea Therapeutics Targeting p53 Cancer Therapies Products Offered
10.7.5 Aprea Therapeutics Recent Development
10.8 Ascentage Pharma
10.8.1 Ascentage Pharma Company Information
10.8.2 Ascentage Pharma Introduction and Business Overview
10.8.3 Ascentage Pharma Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Ascentage Pharma Targeting p53 Cancer Therapies Products Offered
10.8.5 Ascentage Pharma Recent Development
10.9 Jc (Wuxi) Company
10.9.1 Jc (Wuxi) Company Company Information
10.9.2 Jc (Wuxi) Company Introduction and Business Overview
10.9.3 Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Jc (Wuxi) Company Targeting p53 Cancer Therapies Products Offered
10.9.5 Jc (Wuxi) Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Targeting p53 Cancer Therapies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Targeting p53 Cancer Therapies Industrial Chain Analysis
11.4 Targeting p53 Cancer Therapies Market Dynamics
11.4.1 Targeting p53 Cancer Therapies Industry Trends
11.4.2 Targeting p53 Cancer Therapies Market Drivers
11.4.3 Targeting p53 Cancer Therapies Market Challenges
11.4.4 Targeting p53 Cancer Therapies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Targeting p53 Cancer Therapies Distributors
12.3 Targeting p53 Cancer Therapies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Small Molecule Drugs
Table 2. Major Company of Immunotherapy
Table 3. Major Company of Gene Therapy
Table 4. Major Company of Others
Table 5. Global Targeting p53 Cancer Therapies Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (K Units)
Table 7. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US& Million)
Table 9. Global Targeting p53 Cancer Therapies Market Share in Value by Type (2024-2024)
Table 10. Global Targeting p53 Cancer Therapies Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Targeting p53 Cancer Therapies Sales by Type (2024-2034) & (K Units)
Table 12. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Targeting p53 Cancer Therapies Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Targeting p53 Cancer Therapies Sales Market Share in Value by Type (2024-2034)
Table 15. Global Targeting p53 Cancer Therapies Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (K Units)
Table 17. North America Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Targeting p53 Cancer Therapies Sales (K Units) by Type (2024-2024)
Table 19. Europe Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Targeting p53 Cancer Therapies Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Targeting p53 Cancer Therapies Sales (K Units) by Type (2024-2024)
Table 23. Latin America Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Targeting p53 Cancer Therapies Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Targeting p53 Cancer Therapies Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Targeting p53 Cancer Therapies Sales by Company (2024-2024) & (K Units)
Table 27. Global Targeting p53 Cancer Therapies Sales Share by Company (2024-2024)
Table 28. Global Targeting p53 Cancer Therapies Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Targeting p53 Cancer Therapies Revenue Share by Company (2024-2024)
Table 30. Global Market Targeting p53 Cancer Therapies Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Targeting p53 Cancer Therapies Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Targeting p53 Cancer Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeting p53 Cancer Therapies as of 2022)
Table 34. Date of Key Manufacturers Enter into Targeting p53 Cancer Therapies Market
Table 35. Key Manufacturers Targeting p53 Cancer Therapies Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Targeting p53 Cancer Therapies Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Targeting p53 Cancer Therapies Sales by Region (2024-2024) & (K Units)
Table 39. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Targeting p53 Cancer Therapies Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Targeting p53 Cancer Therapies Sales Market Share in Value by Region (2024-2024)
Table 42. Global Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Targeting p53 Cancer Therapies Sales by Region (2024-2034) & (K Units)
Table 44. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Targeting p53 Cancer Therapies Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Targeting p53 Cancer Therapies Sales Market Share in Value by Region (2024-2034)
Table 47. Global Targeting p53 Cancer Therapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Targeting p53 Cancer Therapies Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (K Units)
Table 50. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Targeting p53 Cancer Therapies Sales Market Share in Value by Application (2024-2024)
Table 53. Global Targeting p53 Cancer Therapies Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Targeting p53 Cancer Therapies Sales by Application (2024-2034) & (K Units)
Table 55. Global Targeting p53 Cancer Therapies Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Targeting p53 Cancer Therapies Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Targeting p53 Cancer Therapies Sales Market Share in Value by Application (2024-2034)
Table 58. Global Targeting p53 Cancer Therapies Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Targeting p53 Cancer Therapies Sales by Application (2024-2024) (K Units)
Table 60. North America Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Targeting p53 Cancer Therapies Sales by Application (2024-2024) (K Units)
Table 62. Europe Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Targeting p53 Cancer Therapies Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Targeting p53 Cancer Therapies Sales by Application (2024-2024) (K Units)
Table 66. Latin America Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Targeting p53 Cancer Therapies Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Targeting p53 Cancer Therapies Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (K Units)
Table 70. North America Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2024)
Table 73. North America Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (K Units)
Table 74. North America Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (K Units)
Table 78. Europe Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (K Units)
Table 82. Europe Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Targeting p53 Cancer Therapies Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Targeting p53 Cancer Therapies Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Targeting p53 Cancer Therapies Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Targeting p53 Cancer Therapies Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Targeting p53 Cancer Therapies Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Targeting p53 Cancer Therapies Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Value by Country (2024-2034)
Table 109. Sibiono GeneTech Company Information
Table 110. Sibiono GeneTech Introduction and Business Overview
Table 111. Sibiono GeneTech Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. Sibiono GeneTech Targeting p53 Cancer Therapies Product
Table 113. Sibiono GeneTech Recent Development
Table 114. Kartos Therapeutics Company Information
Table 115. Kartos Therapeutics Introduction and Business Overview
Table 116. Kartos Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Kartos Therapeutics Targeting p53 Cancer Therapies Product
Table 118. Kartos Therapeutics Recent Development
Table 119. SynerGene Therapeutics Company Information
Table 120. SynerGene Therapeutics Introduction and Business Overview
Table 121. SynerGene Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. SynerGene Therapeutics Targeting p53 Cancer Therapies Product
Table 123. SynerGene Therapeutics Recent Development
Table 124. MultiVir Company Information
Table 125. MultiVir Introduction and Business Overview
Table 126. MultiVir Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. MultiVir Targeting p53 Cancer Therapies Product
Table 128. MultiVir Recent Development
Table 129. Rain Oncology Company Information
Table 130. Rain Oncology Introduction and Business Overview
Table 131. Rain Oncology Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Rain Oncology Targeting p53 Cancer Therapies Product
Table 133. Rain Oncology Recent Development
Table 134. Alieron Therapeutics Company Information
Table 135. Alieron Therapeutics Introduction and Business Overview
Table 136. Alieron Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Alieron Therapeutics Targeting p53 Cancer Therapies Product
Table 138. Alieron Therapeutics Recent Development
Table 139. Aprea Therapeutics Company Information
Table 140. Aprea Therapeutics Introduction and Business Overview
Table 141. Aprea Therapeutics Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Aprea Therapeutics Targeting p53 Cancer Therapies Product
Table 143. Aprea Therapeutics Recent Development
Table 144. Ascentage Pharma Company Information
Table 145. Ascentage Pharma Introduction and Business Overview
Table 146. Ascentage Pharma Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Ascentage Pharma Targeting p53 Cancer Therapies Product
Table 148. Ascentage Pharma Recent Development
Table 149. Jc (Wuxi) Company Company Information
Table 150. Jc (Wuxi) Company Introduction and Business Overview
Table 151. Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. Jc (Wuxi) Company Targeting p53 Cancer Therapies Product
Table 153. Jc (Wuxi) Company Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Targeting p53 Cancer Therapies Market Trends
Table 157. Targeting p53 Cancer Therapies Market Drivers
Table 158. Targeting p53 Cancer Therapies Market Challenges
Table 159. Targeting p53 Cancer Therapies Market Restraints
Table 160. Targeting p53 Cancer Therapies Distributors List
Table 161. Targeting p53 Cancer Therapies Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeting p53 Cancer Therapies Product Picture
Figure 2. Global Targeting p53 Cancer Therapies Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Targeting p53 Cancer Therapies Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Targeting p53 Cancer Therapies Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Small Molecule Drugs
Figure 6. Global Small Molecule Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Immunotherapy
Figure 8. Global Immunotherapy Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Gene Therapy
Figure 10. Global Gene Therapy Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Targeting p53 Cancer Therapies Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Targeting p53 Cancer Therapies Sales Market Share by Type in 2022 & 2034
Figure 15. North America Targeting p53 Cancer Therapies Sales Market Share in Volume by Type in 2022
Figure 16. North America Targeting p53 Cancer Therapies Sales Market Share in Value by Type in 2022
Figure 17. Europe Targeting p53 Cancer Therapies Sales Market Share in Volume by Type in 2022
Figure 18. Europe Targeting p53 Cancer Therapies Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Value by Type in 2022
Figure 21. Latin America Targeting p53 Cancer Therapies Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Targeting p53 Cancer Therapies Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeting p53 Cancer Therapies Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeting p53 Cancer Therapies Revenue in 2022
Figure 27. Targeting p53 Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Targeting p53 Cancer Therapies Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Targeting p53 Cancer Therapies Sales Market Share by Application in 2022 & 2034
Figure 36. North America Targeting p53 Cancer Therapies Sales Market Share in Volume by Application in 2022
Figure 37. North America Targeting p53 Cancer Therapies Sales Market Share in Value by Application in 2022
Figure 38. Europe Targeting p53 Cancer Therapies Sales Market Share in Volume by Application in 2022
Figure 39. Europe Targeting p53 Cancer Therapies Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Targeting p53 Cancer Therapies Sales Market Share in Value by Application in 2022
Figure 42. Latin America Targeting p53 Cancer Therapies Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Targeting p53 Cancer Therapies Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Targeting p53 Cancer Therapies Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Targeting p53 Cancer Therapies Manufacturing Cost Structure
Figure 47. Targeting p53 Cancer Therapies Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries